171 related articles for article (PubMed ID: 15293867)
21. Cancer vaccine THERATOPE- Biomira.
Adis International Ltd
Drugs R D; 2003; 4(4):236-40. PubMed ID: 12848588
[TBL] [Abstract][Full Text] [Related]
22. Clofarabine.
Drugs R D; 2004; 5(4):213-7. PubMed ID: 15230627
[TBL] [Abstract][Full Text] [Related]
23. Lasofoxifene: CP 336156, CP-336156.
Drugs R D; 2005; 6(1):56-60. PubMed ID: 15801869
[TBL] [Abstract][Full Text] [Related]
24. Neovastat--a novel antiangiogenic drug for cancer therapy.
Gingras D; Boivin D; Deckers C; Gendron S; Barthomeuf C; BĂ©liveau R
Anticancer Drugs; 2003 Feb; 14(2):91-6. PubMed ID: 12569294
[TBL] [Abstract][Full Text] [Related]
25. Bleomycin--electrical pulse delivery: electroporation therapy-bleomycin--Genetronics; MedPulser-bleomycin--Genetronics.
Drugs R D; 2004; 5(5):293-6. PubMed ID: 15357628
[TBL] [Abstract][Full Text] [Related]
26. AE-941, a multifunctional antiangiogenic compound: trials in renal cell carcinoma.
Bukowski RM
Expert Opin Investig Drugs; 2003 Aug; 12(8):1403-11. PubMed ID: 12882625
[TBL] [Abstract][Full Text] [Related]
27. Calcitonin intranasal--unigene: Salcatonin intranasal--unigene.
Drugs R D; 2004; 5(2):90-3. PubMed ID: 15293868
[TBL] [Abstract][Full Text] [Related]
28. Gadofosveset: MS 325, MS 32520, Vasovist, ZK 236018.
Drugs R D; 2004; 5(6):339-42. PubMed ID: 15563237
[TBL] [Abstract][Full Text] [Related]
29. Amotosalen: Allogeneic Cellular Immunotherapies system, INTERCEPT Plasma System, INTERCEPT Platelet System, S 59.
BioDrugs; 2003; 17(1):66-8. PubMed ID: 12534321
[TBL] [Abstract][Full Text] [Related]
30. AEterna reports on its phase II trial of neovastat.
Expert Rev Anticancer Ther; 2001 Jun; 1(1):3-4. PubMed ID: 12113128
[No Abstract] [Full Text] [Related]
31. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
[TBL] [Abstract][Full Text] [Related]
32. Lobaplatin: D 19466.
Drugs R D; 2003; 4(6):369-72. PubMed ID: 14584968
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronidase (Vitrase)--ISTA: hyaluronidase--ISTA pharmaceuticals.
Drugs R D; 2003; 4(3):194-7. PubMed ID: 12757408
[TBL] [Abstract][Full Text] [Related]
34. Abarelix: abarelix-depot-F, abarelix-depot-M, abarelix-L, PPI 149, R 3827.
Drugs R D; 2003; 4(3):161-6. PubMed ID: 12757402
[TBL] [Abstract][Full Text] [Related]
35. Virulizin.
BioDrugs; 2002; 16(5):374-5. PubMed ID: 12408741
[TBL] [Abstract][Full Text] [Related]
36. Exisulind: Aptosyn, FGN 1, Prevatac, sulindac sulfone.
Drugs R D; 2004; 5(4):220-6. PubMed ID: 15230629
[TBL] [Abstract][Full Text] [Related]
37. Oregovomab: anti-CA-125 monoclonal antibody B43.13--AltaRex, B43.13, MAb B43.13, monoclonal antibody B43.13.
Drugs R D; 2006; 7(6):379-83. PubMed ID: 17073521
[TBL] [Abstract][Full Text] [Related]
38. Vincristine liposomal--INEX: lipid-encapsulated vincristine, onco TCS, transmembrane carrier system--vincristine, vincacine, vincristine sulfate liposomes for injection, VSLI.
Drugs R D; 2004; 5(2):119-23. PubMed ID: 15293876
[TBL] [Abstract][Full Text] [Related]
39. Oblimersen: Augmerosen, BCL-2 antisense oligonucleotide - Genta, G 3139, GC 3139, oblimersen sodium.
Drugs R D; 2007; 8(5):321-34. PubMed ID: 17767397
[TBL] [Abstract][Full Text] [Related]
40. Methylnaltrexone: MNTX.
Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]